NKGen Biotech Statistics

Total Valuation

NKGen Biotech has a market cap or net worth of $20.17 million. The enterprise value is $42.35 million.

Market Cap	20.17M
Enterprise Value	42.35M

Important Dates

The next estimated earnings date is Tuesday, September 17, 2024, before market open.

Earnings Date	Sep 17, 2024
Ex-Dividend Date	n/a

Share Statistics

NKGen Biotech has 25.77 million shares outstanding. The number of shares has increased by 189.50% in one year.

Shares Outstanding	25.77M
Shares Change (YoY)	+189.50%
Shares Change (QoQ)	+1.18%
Owned by Insiders (%)	19.88%
Owned by Institutions (%)	14.24%
Float	6.36M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.04

Current Ratio	0.04
Quick Ratio	0.00
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-17.17

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Capital (ROIC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$1.27M
Employee Count	63
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, NKGen Biotech has paid $7,000 in taxes.

Income Tax	7,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -92.26% in the last 52 weeks. The beta is 0.54, so NKGen Biotech's price volatility has been lower than the market average.

Beta (5Y)	0.54
52-Week Price Change	-92.26%
50-Day Moving Average	1.01
200-Day Moving Average	1.71
Relative Strength Index (RSI)	39.26
Average Volume (20 Days)	141,942

Short Selling Information

The latest short interest is 583,955, so 2.27% of the outstanding shares have been sold short.

Short Interest	583,955
Short Previous Month	610,800
Short % of Shares Out	2.27%
Short % of Float	9.18%
Short Ratio (days to cover)	0.30

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-30.57M
Pretax Income	-80.01M
Net Income	-80.01M
EBITDA	-29.38M
EBIT	-30.57M
Earnings Per Share (EPS)	-$4.55

Full Income Statement

Balance Sheet

The company has $34,000 in cash and $22.21 million in debt, giving a net cash position of -$22.18 million or -$0.86 per share.

Cash & Cash Equivalents	34,000
Total Debt	22.21M
Net Cash	-22.18M
Net Cash Per Share	-$0.86
Equity (Book Value)	-55.06M
Book Value Per Share	-2.46
Working Capital	-35.88M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-21.07M
Capital Expenditures	n/a
Free Cash Flow	-21.07M
FCF Per Share	-$0.82

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NKGen Biotech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-189.50%
Shareholder Yield	-189.50%
Earnings Yield	-396.68%
FCF Yield	-104.45%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1